Skip to main content
Log in

Do Investors Care if Steve Jobs is Healthy?

  • Published:
Atlantic Economic Journal Aims and scope Submit manuscript

“Great things in business are not done by one person; they are done by a team of people.” Steve Jobs (2002)

“Apple’s stock has fluctuated on concerns about Mr. Jobs’ health for more than a year.” Joseph Menn and Richard Waters (2009)

Abstract

Steve Jobs of Apple, Inc., is one of the best known CEOs in the world, and some stock analysts have termed him “irreplaceable.” Using conventional event study methods, we test the magnitude of these announcements on Apple’s share price and its market capitalization. We focus upon nine “events” between 2004 and 2009 in which new information about Mr. Jobs’ health was flushed into the marketplace, on occasion by Apple itself, but more often by the commentary and speculations of media observers, stock analysts and bloggers. We find that the impact of these announcements upon Apple share prices is mixed, usually modest, and disappears over time. We conclude that Jobs’ health has an impact on Apple’s share price and market capitalization, but that impact is not always negative and not nearly as large as many observers apparently believe.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Notes

  1. Apparently Munster changed his mind. He previously stated in 2007 that if Jobs were to leave Apple that “It would be a disaster. He would be almost impossible to replace.” (Guglielmo 2007).

  2. The NASDAQ index was used as an estimate of the market return. Our results are materially unchanged using other indexes such as the Dow Jones index, or indexes limited to technology firms.

  3. Table 1 results are based on a 30-day trading day estimation window between May 28, 2010 and July 13, 2010. The period was chosen to avoid contamination that otherwise might have occurred because of Apple’s earnings announcement on July 14, 2004. By itself, this latter event resulted in an abnormal stock return. A regression using a 30-day trading day estimation window between June 18, 2004 and July 30,2004 (which includes the abnormal earning event July 15, 2004 trading day) resulted in a DAR on the first day in the event period of -2.72% (p = 0.305). Using the intervention method (Hakala 2010) to control for the July 15, 2004 announcement and also using the June 18-July 30 estimation window resulted in a first day DAR of -2.67% (p = 0.318).

  4. One could argue that the August 2, 2004 and the June 22, 2008 events might have been viewed as positive news about Jobs’ health because he was not in extremis. The August 2 event news was that Jobs had a treatable form of pancreatic cancer and the June 22, 2008 event news was an announcement by Apple claiming that Jobs’ health was not impaired. If we set these two events aside, our estimates of the impact of Jobs’ health on Apple’s market capitalization are not materially changed. We estimate that the remaining seven “health” events reduced Apple’s market capitalization by $1.8 billion.

  5. The abnormal return is positive, not negative, for the event where the p-value is below the 0.10 threshold and above the 0.05 threshold positive.

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James V. Koch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koch, J.V., Fenili, R.N. & Cebula, R.J. Do Investors Care if Steve Jobs is Healthy?. Atl Econ J 39, 59–70 (2011). https://doi.org/10.1007/s11293-010-9261-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11293-010-9261-z

Keywords

Navigation